5-Fluorouracil (5-Fu; NSC-19893), 5-(3,3-dimethyl-1-triazeno)imidazole-4-carboxamide (NSC-45388), vincristine (NSC-67574), and 1,3-bis(2-chloroethyl)-2-nitrosourea (BCNU; NSC-409962) given concomitantly in the treatment of solid tumors in man.
D000328:Adult; D000368:Aged; D000477:Alkylating Agents / Q000627:therapeutic use*; D000577:Amides / Q000627:therapeutic use; D002330:Carmustine / Q000627:therapeutic use; D004338:Drug Combinations; D005260:Female; D005472:Fluorouracil / Q000627:therapeutic use*; D006801:Humans; D007093:Imidazoles / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D009362:Neoplasm Metastasis; D009369:Neoplasms / Q000188:drug therapy*; D009603:Nitroso Compounds / Q000627:therapeutic use*; D014226:Triazenes / Q000627:therapeutic use; D014508:Urea / Q000627:therapeutic use*; D014750:Vincristine / Q000627:therapeutic use*
D000477:Alkylating Agents; D000577:Amides; D004338:Drug Combinations; D007093:Imidazoles; D009603:Nitroso Compounds; D014226:Triazenes; D014750:Vincristine; D014508:Urea; D005472:Fluorouracil; D002330:Carmustine